North America Body Composition Analyzers Market

North America Body Composition Analyzers Market Size (2023 to 2028)

As per the research report, the Body Composition Analyzers Market size in North America was valued at USD 197.52 million in 2023. It is further expected to be growing at a CAGR of 13.8% and worth USD 376.98 million by 2028.

The functioning of a Body Composition Analyzers involves gauging the percentages of fat, bone, water, and muscle present in the human body. BCAs are useful in determining leanness since muscle mass takes up lesser space than fat by weight, making it difficult to judge body fat without accurate measurements.

Healthy body composition refers to the one that includes a lower proportion of body fat and a higher proportion of fat-free or lean mass. Since muscular tissue takes up lesser space in the body compared to fat tissue, leanness is determined by the bodyweight and body composition. Body composition analyzers determine body composition and aid in determining the risk of individuals developing diseases like truncal and abdominal obesity.

The North American Body Composition Analyzers Market's growth is mainly driven by the increasing consciousness of people towards health and fitness. Furthermore, the rising obese populace, the increasing utility of these analyzers in the sports and fitness industry, and the growing government initiatives to encourage fitness consciousness and physical activity among people are expected to be the drivers of market growth.

However, the high cost of the equipment and the inaccuracy of various analyzers are some of the market's constraints.

This research report on the North America Body Composition Analyzers Market has been segmented and sub-segmented into the following categories:

By Product: 

• Bio-impedance Analyser
• DEXA
• Skinfold Callipers
• ADP
• Hydrostatic Weighing

By End-users: 

• Hospitals
• Fitness & Wellness Centres
• Academic & Research Centres
• Home-users

By Country: 

• The United States
• Canada
• Rest of North America

North America took the major chunk of the Global Body Composition Analyzers Market share in 2022, with the United States accounting for the major share in the region. Swift introduction of newer technologies in Body Composition Analyzers, supplemented by the increasing awareness about health and fitness, are driving the North American Body Composition Analyzers Market. The presence of major global market players in North America is also a major contributor to market growth.

Companies playing a dominant role in the North American Body Composition Analyzers Market profiled in this report are InBody Co., Ltd (South Korea), Tanita Corporation (Japan), Omron Corporation (Japan), Hologic, Inc. (U.S.), and GE Healthcare (U.S.) among others.